Vicki L. Coffin

1.8k total citations
41 papers, 1.4k citations indexed

About

Vicki L. Coffin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Vicki L. Coffin has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cellular and Molecular Neuroscience, 25 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Vicki L. Coffin's work include Receptor Mechanisms and Signaling (20 papers), Neuroscience and Neuropharmacology Research (19 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Vicki L. Coffin is often cited by papers focused on Receptor Mechanisms and Signaling (20 papers), Neuroscience and Neuropharmacology Research (19 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Vicki L. Coffin collaborates with scholars based in United States, Canada and United Kingdom. Vicki L. Coffin's co-authors include Richard E. Chipkin, S. Barak Caine, George F. Koob, Stephen C. Heinrichs, Roger D. Spealman, John W. Phillis, Robin A. Barraco, Harvey J. Altman, Richard McQuade and A Barnett and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Vicki L. Coffin

40 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicki L. Coffin United States 21 998 676 223 211 211 41 1.4k
M.B. Emerit France 25 1.4k 1.4× 1.2k 1.8× 180 0.8× 155 0.7× 86 0.4× 49 2.1k
G. Zsilla Hungary 21 763 0.8× 482 0.7× 166 0.7× 156 0.7× 113 0.5× 38 1.2k
Roy Corbett United States 20 982 1.0× 527 0.8× 70 0.3× 289 1.4× 287 1.4× 34 1.5k
A.R. Knight United States 7 1.4k 1.4× 1.0k 1.5× 56 0.3× 231 1.1× 149 0.7× 16 1.8k
C.C. Mao United States 14 971 1.0× 576 0.9× 67 0.3× 204 1.0× 165 0.8× 19 1.5k
Vincent J. Aloyo United States 23 1.2k 1.2× 794 1.2× 71 0.3× 187 0.9× 60 0.3× 74 1.7k
Leah Aluisio United States 24 391 0.4× 473 0.7× 264 1.2× 568 2.7× 147 0.7× 32 1.7k
R.A. Rabin United States 21 1.2k 1.2× 524 0.8× 54 0.2× 118 0.6× 66 0.3× 51 1.5k
George G. Yarbrough United States 23 1.1k 1.1× 657 1.0× 84 0.4× 107 0.5× 61 0.3× 48 1.7k
Andrea M. Martino United States 10 498 0.5× 546 0.8× 152 0.7× 116 0.5× 87 0.4× 11 873

Countries citing papers authored by Vicki L. Coffin

Since Specialization
Citations

This map shows the geographic impact of Vicki L. Coffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki L. Coffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki L. Coffin more than expected).

Fields of papers citing papers by Vicki L. Coffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki L. Coffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki L. Coffin. The network helps show where Vicki L. Coffin may publish in the future.

Co-authorship network of co-authors of Vicki L. Coffin

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki L. Coffin. A scholar is included among the top collaborators of Vicki L. Coffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki L. Coffin. Vicki L. Coffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Varty, Geoffrey B., Sherry Lu, Cynthia A. Morgan, et al.. (2008). The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). Journal of Pharmacology and Experimental Therapeutics. 326(2). 672–682. 67 indexed citations
2.
Shue, Ho‐Jane, Xiao Chen, Neng‐Yang Shih, et al.. (2005). Cyclic urea derivatives as potent NK1 selective antagonists. Bioorganic & Medicinal Chemistry Letters. 15(17). 3896–3899. 40 indexed citations
3.
Carey, Galen, William Billard, Herbert Binch, et al.. (2001). SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals. European Journal of Pharmacology. 431(2). 189–200. 59 indexed citations
4.
Romach, Myroslava K., Paul Glue, Kyle M. Kampman, et al.. (1999). Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166). Archives of General Psychiatry. 56(12). 1101–1101. 89 indexed citations
5.
Howell, Leonard L., Vicki L. Coffin, & Roger D. Spealman. (1997). Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology. 129(1). 1–14. 51 indexed citations
6.
Coffin, Vicki L., et al.. (1994). Feibamate, a novel antiepileptic agent, does not affect cognition in rodents. Behavioural Pharmacology. 5(3). 365–368. 12 indexed citations
7.
Smith, Richard, et al.. (1994). Methylatropine blocks the central effects of cholinergic antagonists. Behavioural Pharmacology. 5(2). 167–175. 12 indexed citations
8.
Tedford, Clark E., Vicki L. Coffin, Vilma Ruperto, et al.. (1993). Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in rats. Psychopharmacology. 113(2). 199–204. 10 indexed citations
9.
Kozlowski, Joseph A., Derek Lowe, Henry Guzik, et al.. (1992). Dopamine receptor binding properties of some 2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols with non-aromatic substituents in the 5-position. Bioorganic & Medicinal Chemistry Letters. 2(5). 399–402. 3 indexed citations
10.
McQuade, Robert D., Ruth A. Duffy, Vicki L. Coffin, & Allen Barnett. (1992). In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity. European Journal of Pharmacology. 215(1). 29–34. 19 indexed citations
11.
Tedford, Clark E., et al.. (1992). SCH 39166, a novel dopamine D1 receptor antagonist: In vitro investigation of its glucuronidation and potential species differences. Drug Development Research. 26(4). 389–403. 9 indexed citations
12.
Coffin, Vicki L., et al.. (1992). SCH 39166, a potential antipsychotic drug, does not evoke movement disorders in cebus monkeys. Neurochemistry International. 20. 141–145. 15 indexed citations
13.
McQuade, Richard, Ruth A. Duffy, Vicki L. Coffin, Richard E. Chipkin, & A Barnett. (1991). In vivo binding of SCH 39166: a D-1 selective antagonist.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 42–49. 32 indexed citations
14.
Mchugh, Daniel & Vicki L. Coffin. (1991). The reversal of extrapyramidal side effects with SCH 39166, a dopamine D1 receptor antagonist. European Journal of Pharmacology. 202(1). 133–134. 27 indexed citations
15.
McQuade, Robert D., Ruth A. Duffy, Gordon Crosby, et al.. (1991). [3H]SCH 39166, A New D1‐Selective Radioligand: In Vitro and In Vivo Binding Analyses. Journal of Neurochemistry. 57(6). 2001–2010. 32 indexed citations
16.
Coffin, Vicki L. & Roger D. Spealman. (1989). Psychomotor-stimulant effects of 3-isobutyl-1-methylxanthine: Comparison with caffeine and 7-(2-chloroethyl) theophylline. European Journal of Pharmacology. 170(1-2). 35–40. 12 indexed citations
17.
Chipkin, Richard E., Louis C. Iorio, Vicki L. Coffin, et al.. (1988). Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.. Journal of Pharmacology and Experimental Therapeutics. 247(3). 1093–1102. 150 indexed citations
18.
Spealman, Roger D. & Vicki L. Coffin. (1986). Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors. Psychopharmacology. 90(3). 419–21. 33 indexed citations
19.
Coffin, Vicki L. & Roger D. Spealman. (1985). Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.. Journal of Pharmacology and Experimental Therapeutics. 235(3). 724–728. 22 indexed citations
20.
Wu, P.H. & Vicki L. Coffin. (1984). Up-regulation of brain [3H]diazepam binding sites in chronic caffeine-treated rats. Brain Research. 294(1). 186–189. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.B. Emerit Breakdown of academic impact, for papers by G. Zsilla Breakdown of academic impact, for papers by Roy Corbett Breakdown of academic impact, for papers by A.R. Knight Breakdown of academic impact, for papers by C.C. Mao Breakdown of academic impact, for papers by Vincent J. Aloyo Breakdown of academic impact, for papers by Leah Aluisio Breakdown of academic impact, for papers by R.A. Rabin Breakdown of academic impact, for papers by George G. Yarbrough Breakdown of academic impact, for papers by Andrea M. Martino
Rankless by CCL
2026